Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
Titel:
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
Auteur:
Di Giacomo, A.M. Ascierto, P.A. Queirolo, P. Pilla, L. Ridolfi, R. Santinami, M. Testori, A. Simeone, E. Guidoboni, M. Maurichi, A. Orgiano, L. Spadola, G. Del Vecchio, M. Danielli, R. CalabrĂ², L. Annesi, D. Giannarelli, D. Maccalli, C. Fonsatti, E. Parmiani, G. Maio, M.